May 12, 2022
Sema4 Reports First Quarter 2022 Financial Results and Business Highlights
May 4, 2022
Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 2, 2022
Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms
April 26, 2022
Sema4 to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
April 6, 2022
Sema4 Achieves HITRUST CSF Certification
April 5, 2022
Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy
March 16, 2022
Sema4 Announces Nationwide Expansion of Disparity Study to Deliver Precision Oncology Care to Underserved Communities
March 14, 2022
Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
March 8, 2022
Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022
February 22, 2022
Sema4 to Report Fourth Quarter and Full Year 2021 Financial Results and Participate in Investor Conferences in March 2022
Displaying 1 - 10 of 16